Determination of the effect of broccoli sprouts on inflammation in patients with diabetes
Not Applicable
- Conditions
- Type 2 diabetes.
- Registration Number
- IRCT2013070810190N4
- Lead Sponsor
- Research deputy of Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusion: Patients with type 2 diabetes with at least 3 years from the onset of the disease.
Exclusion: Insulin therapy, taking especial medications such as hormones, hypoglycemic agents, and lipid lowering medications, vitamin and iron supplements, vitamin K antagonists, those with nephropathy, neuropathy, and cardiovascular disease, liver disease, cancers, autoimmune and inflammatory diseases, pregnant and lactating women, smokers, and those on especial diets, and those who make major changes in their diet during intervention.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method C reactive protein. Timepoint: At the beginning of study and at the end of intervention. Method of measurement: Biochemical analysis.;Tumor necrosis factor-alpha. Timepoint: At the beginning of study and at the end of intervention. Method of measurement: Biochemical analysis.;Interleukin-6. Timepoint: At the beginning of study and at the end of intervention. Method of measurement: Biochemical analysis.
- Secondary Outcome Measures
Name Time Method Body mass index. Timepoint: At the beginning and at the end of study. Method of measurement: Weighing.